Neuron vs Molecular Cell: Which Should You Submit To?

• the work is explicitly about nervous system function, neural circuits, or brain disease

• your primary audience is neuroscientists

• the paper's significance comes from what it reveals about neural mechanisms

• you're building a neuroscience career and want the field's flagship journal

• the mechanism you discovered applies broadly to cell biology, not just neurons

• the strongest version of the paper emphasizes general cellular principles

• your audience is cell biologists who happen to work on neuronal systems among others

• any current same-release citation-metric difference matters for a documented institutional requirement

If a citation metric matters for reporting, compare the current same-release JCR rows and record the data year. Do not use a mixed-year difference to choose the paper's audience. Neuron has stronger neuroscience ownership; Molecular Cell has stronger molecular and cellular mechanism ownership. The manuscript should go to the community for which its central result is indispensable.

Neuron publishes research on the nervous system: neurophysiology, neurodevelopment, synaptic mechanisms, neural circuit function, behavioral neuroscience, neuroimmunology, neuroinflammation, and translational neuroscience. The journal spans molecular mechanisms, cellular neuroscience, systems neuroscience, and behavioral/cognitive aspects of the nervous system.

Molecular Cell publishes mechanistic cell biology broadly: transcriptional regulation, signal transduction, protein trafficking, RNA mechanisms, cell cycle, cell differentiation, organellar dynamics, metabolic regulation, and cell-cell interactions. The journal emphasizes molecular mechanisms of cellular processes with general applicability.

The key difference: Neuron accepts research on any aspect of the nervous system. Molecular Cell accepts mechanistic cell biology research from any system, including neurons, but does not prioritize nervous system-specific studies. A study of transcriptional regulation in neurons would fit both. A study of neural circuit function would fit only Neuron. A study of protein trafficking in a non-neuronal system would fit only Molecular Cell.

Neuron values studies that illuminate nervous system function or advance understanding of brain disease. The journal is interested in mechanistic work that provides insight into how neurons or neural circuits work, or studies that have implications for neurological or psychiatric disorders.

Molecular Cell values studies that reveal general principles of cell biology - mechanisms that apply broadly across cell types or systems. The journal asks: "Does this advance our understanding of how cells work?" Neuron-specific applications are secondary.

In practice: A study of a protein kinase's role in synaptic plasticity would be strong for Neuron (specific to nervous system function) but might be viewed by Molecular Cell editors as neuroscience-specific rather than broadly relevant cell biology. Conversely, a study of a ubiquitin ligase's role in protein quality control would be strong for Molecular Cell regardless of tissue context.

Neuron editors are selective but fair. Papers without clear neuroscience relevance, those with insufficient mechanistic rigor, or incremental studies are desk-rejected. But papers that address genuine questions about nervous system function and are well-executed have a fair shot at peer review.

Molecular Cell editors are rigorous. They expect papers to reveal general principles with broad applicability. Tissue- or disease-specific findings, even if mechanistically interesting, may be desk-rejected if they're not seen as advancing broader cell biology understanding. The bar for peer review is high.

In practical terms: Mechanistic neuroscience papers may have an easier path to peer review at Neuron than at Molecular Cell, even if the mechanism itself is novel.

The official pages reviewed do not provide comparable current manuscript-level acceptance denominators. Third-party percentages cannot establish which journal is more likely to accept this paper. The defensible distinction is scientific ownership: neural consequence for Neuron, transferable cell mechanism for Molecular Cell.

Neuron: 4 days to first decision on the current Cell Press insights page.

Molecular Cell: The current Cell Press insights data lists 170 days from submission to acceptance; Manusights still treats the first-decision timing itself as less firmly verified than Neuron's.

Decision time varies by manuscript, editor, reviewer availability, and revision history. Do not turn one journal insight metric into a guaranteed project schedule.

If your research is explicitly about nervous system function or brain disease: Neuron is the natural choice. It's the field's default journal, and your audience is neuroscientists.

If your research is mechanistic cell biology from a non-neuronal system: Only Molecular Cell applies.

If your research is mechanistic cell biology from neurons, but the principles apply broadly: Molecular Cell may be the better fit. Frame the work as general cell biology that happens to use neurons as a model system; the deciding advantage is broader mechanistic ownership, not a copied metric difference.

If your research is synaptic mechanism or neural circuit function: Neuron only. Molecular Cell doesn't specialize in circuit-level neuroscience.

If your research is neuroinflammation, neuroimmunology, or a neuron-brain disease interaction: Neuron, unless the mechanism is non-tissue-specific cell biology. Then consider Molecular Cell.

If you're unsure: Neuron is the safer choice if you're a neuroscientist. Your audience is there, and the journal values nervous system relevance. Molecular Cell is the higher-impact choice if your mechanism is truly broadly applicable.

If Neuron rejects your mechanistic neuroscience paper, Molecular Cell is a logical second submission - especially if your mechanism has general cell biology implications. Molecular Cell editors may see broad significance that Neuron editors didn't. The feedback from Neuron can help refocus the manuscript for Molecular Cell's cell biology audience.

Conversely, if Molecular Cell rejects your neuroscience paper as too tissue-specific, Neuron becomes the next logical target. The revision is usually minimal - adjust the framing to emphasize nervous system significance rather than general cell biology.

Don't submit to both simultaneously; choose one based on your framing and target audience, then use rejection as feedback to decide whether to revise and try the other.

Molecular Cell is higher-impact overall but cares most about broad cellular principles. Neuron is lower-impact on paper but is the home of neuroscience research and deeply valued by the neuroscience community. For mechanistic neuroscience, the choice depends on whether your mechanism has general cell biology implications (Molecular Cell) or is primarily interesting to neuroscientists (Neuron). Most successful neuroscience papers find their home at Neuron. Molecular Cell is the choice when your work transcends neuroscience-specific interests.

If you are weighing Neuron against Molecular Cell and want an outside perspective on which framing is stronger, a Neuron vs Molecular Cell scope and framing check can assess scope fit and likely editorial response for each journal.

Replace the named assay or platform with “[method]” in the title and abstract. What scientific consequence remains?

This test prevents a fashionable technique from deciding the journal when the consequence should.

Neuron offers the right audience when the mechanism changes an account of neural function, circuitry, behavior, or brain disease. Molecular Cell offers the right audience when the mechanism remains a general cell-biological principle after the neural setting is removed. A slightly higher metric cannot compensate for asking the wrong readership to supply the paper's significance.

First remove the neural setting from the manuscript. If the central conclusion still changes a general molecular or cellular principle, Molecular Cell may own the stronger reader job. Then remove the molecular technique or mechanistic detail. If the conclusion still changes how researchers understand neural function, circuit behavior, cognition, or neurological disease, Neuron may be the stronger owner.

The point is not to strip either dimension from the final paper. It is to identify which dimension makes the result consequential. A sophisticated molecular method does not by itself create a Molecular Cell paper, and a brain-derived sample does not by itself create a Neuron paper. Route by the conclusion that would be lost, then make the title, abstract, first figure, and discussion foreground that same biological consequence.

Cell Press journal descriptions and author resources provide the official scope and submission facts. Public timing and selectivity ranges are planning context rather than guarantees. The biological-consequence test and technique-removal counterfactual are Manusights editorial synthesis; they are not unpublished Cell Press criteria and do not predict an outcome.

This comparison is useful for mechanistic papers whose experiments are neural but whose claim may be broader cell biology. Pros and cons: Neuron concentrates the neuroscience audience but requires the neural consequence to be indispensable; Molecular Cell supports a wider mechanistic audience but requires the principle to travel beyond neural context. That use-case boundary is more actionable than comparing prestige in isolation.